← Open Payments lookup

CHRISTINE DAVIDSON: Open Payments

NPI 1801265368 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,376 in 46 payments from 10 companies in 2025. Trend: 2023 $157 · 2024 $271 · 2025 $1,376

Food & beverage: $1,376
CompanyPaymentsAmount
ABBVIE INC.14$321
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$301
Braeburn Inc.7$217
Otsuka America Pharmaceutical, Inc.6$210
Neurocrine BioSciences, Inc.2$134
Lundbeck LLC3$59
Indivior Inc.3$47
Takeda Pharmaceuticals U.S.A., Inc.2$35
Almatica Pharma LLC1$28
Bausch Health US, LLC1$23

Products named: CAPLYTA, REXULTI, VRAYLAR, BRIXADI, INGREZZA, MAVYRET, SUBLOCADE, TRINTELLIX.

Industry payments across MD — which companies pay providers there.